doi:10.1016/j.jmb.2008.06.043
J. Mol. Biol. (2008) 381, 1332–1348
Available online at www.sciencedirect.com
β-Lactoglobulin Assembles into Amyloid through
Sequential Aggregated Intermediates
Jason T. Giurleo, Xianglan He and David S. Talaga⁎
Department of Chemistry and
Chemical Biology, Rutgers,
The State University of New
Jersey, 610 Taylor Road,
Piscataway, NJ 08854, USA
Received 8 April 2008;
received in revised form
22 May 2008;
accepted 16 June 2008
Available online
20 June 2008
We have investigated the aggregation and amyloid fibril formation of
bovine β-lactoglobulin variant A, with a focus on the early stages of
aggregation. We used noncovalent labeling with thioflavin T and 1-anilino8-naphthalenesulfonate to follow the conformational changes occurring in
β-lactoglobulin during aggregation using time resolved luminescence. 1Anilino-8-naphthalenesulfonate monitored the involvement of the hydrophobic core/calyx of β-lactoglobulin in the aggregation process. Thioflavin
T luminescence monitored the formation of amyloid. The luminescence
lifetime distributions of both probes showed changes that could be
attributed to conformational changes occurring during and following
aggregation. To correlate the luminescence measurements with the degree
of aggregation and the morphology of the aggregates, we also measured
dynamic light scattering and atomic force microscopy images. We
evaluated the relative stability of the intermediates with an assay that is
sensitive to aggregation reversibility. Our results suggest that initial
aggregation during the first 5 days occurred with partial disruption of the
characteristic calyx in β-lactoglobulin. As the globular aggregates grew
from days 5 to 16, the calyx was completely disrupted and the globular
aggregates became more stable. After this second phase of aggregation,
conversion into a fibrillar form occurred, marking the growth phase, and
still more changes in the luminescence signals were observed. Based on
these observations, we propose a three-step process by which monomer is
converted first into weakly associated aggregates, which rearrange into
stable aggregates, which eventually convert into protofibrils that elongate
in the growth phase.
© 2008 Elsevier Ltd. All rights reserved.
Edited by K. Kuwajima
Keywords: lipocalin; fluorescence; dynamic light scattering; protein aggregation;
amyloid
Introduction
Amyloid formation
Aggregation of soluble polypeptides or proteins
into insoluble amyloid fibrils containing the cross-β
*Corresponding author. E-mail address:
talaga@rutgers.edu.
Abbreviations used: AFM, atomic force microscopy;
ANS, 1-anilino-8-naphthalenesulfonate; β-LGa, βlactoglobulin variant A; GIPG, globally regularized
interior point gradient; DLS, dynamic light scattering;
ThT, thioflavin T; AggA, aggregate A; AggB, aggregate B;
APTES, aminopropyltriethoxysilane; TCSPC, timecorrelated single-photon counting.
structural motif has been observed in the progression of more than 20 diseases.1 The human health
impact of these diseases has motivated intensive
study and numerous reviews of the structure and
growth of amyloid fibrils.1–9
Amyloid formation often shows a sigmoidal
kinetic growth pattern. Early times are characterized
by a lag phase, where little or no fibrillar growth is
observed. The growth phase, where amyloid rapidly
assembles, follows. The reaction then slows, with
amyloid accumulation reaching a plateau.1,10,11
After this point, amyloid often begins to gel or
precipitate in vitro. The durations of the lag phase
and the growth phase both change dramatically
depending on the incubation conditions.12–14
The kinetic lag phase for many amyloidogenic
precursors is characterized by conversion of soluble
monomers into small oligomers.10,14,15 One of the
0022-2836/$ - see front matter © 2008 Elsevier Ltd. All rights reserved.
1333
β-Lactoglobulin Assembly into Amyloid
driving forces for initial aggregation of soluble
globular proteins may be the partitioning of hydrophobic side chains into a central core, much like
protein folding.16 The structural content and contribution to amyloid assembly of the small oligomers are usually only inferred.17,18 During the lag
phase, there is little appreciable amyloid formation,
as determined by histological assays. The lag time
can be reduced or eliminated by addition of mature
amyloid, as observed in vivo by mortality of the
organism and/or autopsy with histological
staining19 and as observed in vitro by light scattering
or staining.12,20,21 This leads most investigators to
associate the lag phase with the formation of a
critical seed or nucleus.15,17,20,22 The kinetic evidence
of a critical seed has not been corroborated by either
structural evidence identifying it or direct mechanistic information on how it forms and grows.
The kinetic growth phase shows rapid assembly of
amyloid. Amyloid filaments and fibrils have been
identified in atomic force microscopy (AFM) and
electron microscopy images during and after the
growth phase.21,23–26 During the growth phase, it is
most often observed that the kinetic rate is first order
with respect to precursor concentration.13,27,28 Based
on images and simple kinetics, mechanisms have
been proposed,11 but are not well-established. A
template or seed has been proposed to be required
for the growth phase to occur.29 Growth then occurs
as the template either actively induces structural
changes in other species or passively aggregates
with other species with the correct template.30
Recent evidence has shifted some of the focus from
amyloid fibrils to prefibrillar amyloidogenic aggregates as the cause of Alzheimer's disease
symptoms,2,18 leading many to propose the development of vaccines targeting small amyloidogenic
aggregates.4,6,31 Distinguishing between small oligomers that are harmless and those that either are
toxic in their own right or lead to formation of
amyloid fibrils remains a challenge.18
Many amyloidogenic peptides and proteins exhibit conformational polymorphism; they can exist in
multiple stable conformations.32 Conformational
changes are typically observed during amyloid
assembly. In their native state, the precursor
proteins may not, in general, contain the secondary
structural elements present in the final amyloid
assembly.33 The amide I infrared absorption or
Raman band has been observed to lose intensity
associated with the native state and to gain intensity
associated with cross-β.25,32,34,35 Circular dichroism
of the peptide backbone absorption band is also
sensitive to secondary structure and has given
similar results.36,37 Fluorescence spectroscopy has
been used to detect conformational changes either
by noncovalent labeling with dyes such as 1-anilino8-naphthalenesulfonate (ANS) that are specific for
exposed hydrophobic patches38–41 or by covalent
attachment of fluorescent dyes.42,43
Bovine β-lactoglobulin variant A
We investigate the mechanism of amyloid formation from β-lactoglobulin variant A (β-LGa), with a
particular focus on the aggregation and structural
changes occurring during the lag phase. Bovine βLGa (molecular mass, 18.3 kDa/monomer) is a
member of the lipocalin superfamily of proteins
consisting of a flattened β-barrel or calyx comprising
eight β-strands (Fig. 1). β-LGa also has a partial
ninth β-strand and a three-turn α-helix.45 β-LGa is
dimeric under native conditions. β-LGa has two
disulfide bridges and a single free cysteine that has
been observed to undergo disulfide exchange only
when denatured.46
β-LGa has been shown to form amyloid
fibrils.13,25,37,47 The folding behavior of β-LGa has
been extensively studied using bulk experiments.46
β-LGa has structural elements that are conformationally labile.48–53 β-LGa can exist in an equilibrium
between folded, partially structured, and unfolded
states.13,37,48–58 β-LGa has been reported to form
nonnative α-helices prior to complete folding.13,49–56
NMR has shown that these α-helices must melt
and form a β-strand to complete the native-state
Fig. 1. The possible binding sites
of ANS to β-LGa. Hydrophobic
amino acid residues are in slate;
hydrophilic residues are in brick.
ANS was docked to β-LGa using
PyMOL and minimized using the
molecular mechanics software
IMPACT.44 The left panel is a 16-Å
slab of the van der Waals surface
without secondary structure illustrating the binding of ANS in the
hydrophobic calyx site (a). The
right panel is rotated 90° about the
vertical axis of the left panel to
show the postulated intercalation
site in the hydrophobic region
between the main α-helix and the β-barrel surface patch (b). Roughly two-thirds of the calyx volume is represented by
its “mouth” and may be considered to be a third ANS binding site (c).
1334
structure.53 The stabilization of β-LGa by trehalose
was studied using acrylodan covalently attached to
cysteine 121, which showed conformationally sensitive fluorescence. Conformational fluctuations in
β-LGa were transmitted to the local environment
of the attached acrylodan, resulting in a spectral
shift, as well as in lifetime, intensity, and anisotropy
changes.59
Biophysical approaches to aggregation
In this study, we use ANS fluorescence lifetime
distributions to follow the aggregation of β-LGa
through its lag-phase intermediates until it forms
amyloid fibrils. It has been previously reported that
the fluorescence lifetime of ANS is influenced by
the polarity of its binding environment, specific
interactions with amino acid side chains, and the
relative orientation and mobility of the anilino
group.60 ANS binds to hydrophobic regions of
proteins61 and has been extensively used to probe
the presence of the molten globule state and the
assembly of partially structured proteins.13,40,62
ANS has been observed to have different fluorescence intensity properties when bound to different
types of protein aggregates.63 β-LGa binds ANS in
several ways59; one way is through the calyx, which
results in a sequestered ANS with a very long
lifetime (see Fig. 1). ANS probes both the presence
and the integrity of this calyx as well as the overall
exposure of hydrophobic groups in β-LGa. The
calyx is of particular interest because it is the
majority of the hydrophobic core of β-LGa. Disruption of this core is required for an aggregate to
fulfill the geometric constraints of the cross-β
structure of an amyloid fibril. We use our globally
regularized interior point gradient (GIPG) fitting
procedure that fits all the data simultaneously to
resolve the contributions of different ANS binding
sites to the fluorescence lifetime decay.64
We expect aggregation to be driven, in part, by
hydrophobic forces. Therefore, the parts of the
protein that can bind ANS should be structurally
changed by aggregation. The ability to detect the
presence of an intact calyx by virtue of ANS binding
allows determination of the involvement of, and
structural changes in, the protein hydrophobic core
during amyloidogenic incubation. If the aggregation
process is hydrophobically driven, then we expect
the aggregate to sequester hydrophobic residues
changing the structure of the calyx. Alternatively, if
hydrophobicity is the key driving force for conversion into the cross-β structure, then the large
changes in the calyx should occur at that point in
the incubation. In either case, the sensitivity of ANS
to its binding environment should be reflected in its
fluorescence lifetime distribution.
We confirm early stages of aggregation using
dynamic light scattering (DLS). DLS has been used
extensively to characterize protein aggregation and
the growth of amyloid.65,66 We explicitly evaluate
the evolution of the particle size distribution using
the GIPG fitting procedure.64
β-Lactoglobulin Assembly into Amyloid
We assay for the presence of amyloid using
thioflavin T (ThT) luminescence. When bound to
amyloid, ThT exhibits a new absorption band at
450 nm, which has been attributed to ThT binding to
the cross-β structure.13,67–70 The spectroscopic properties of ThT in amyloid are consistent with a
behavior that has been attributed to ThT dimer
formation.71–73 The lifetime of such a dimer will
depend on its environment and geometry, and some
contribution of the luminescence may arise from
non-amyloid-binding modes.74 Using a ThT luminescence lifetime assay, we exploit this to detect the
presence of various amyloid-like structures. The
different lifetime distribution contributions and
their evolution are determined using the GIPG
procedure.
We determine the morphology of the aggregates
using AFM imaging. Imaging techniques such as
AFM have provided an invaluable way to determine
the gross morphology of amyloid protofibrils
(single-stranded) and fibrils (multistranded).23,25,26,75
Results
AFM shows sequential growth of aggregates
Figure 2 shows AFM images taken on several days
of the incubation. The images are false-colored by
height to emphasize the contrast between different
classes of particles. AFM images taken from days 0
to 9 of the incubation did not show significant signs
of aggregation. The protein deposited as a uniform
coating on the functionalized mica surface (brown
background in Fig. 2). Starting from day 10 of the
incubation, we began to see small round aggregates
(green dots in Fig. 2) that grew in size and number
through day 22 (orange dots in Fig. 2). After day 22,
the number and length of oblong protofibrils
increased (purple bars in Fig. 2). Eventually, long
fibrillar aggregates were observed (Fig. 2). Large
amorphous aggregates were also observed (white
features in Fig. 2) but appeared to evolve independently of the other species.
The AFM results suggest two acts to aggregate
growth. The first act consists of formation of round
aggregates that can be stably imaged on the
functionalized mica surface. The second act features the elongation of protofibrils. Each of these
processes appears to have an induction period of
8–10 days under our incubation conditions. A
complete analysis of the evolution of the AFM
particle size distribution is the subject of a forthcoming article.
DLS resolves early lag-phase aggregation
DLS correlation functions were measured every
15 min for 4.7 days to investigate the earliest
aggregation events. Distributions of correlation
decay times appear in Fig. 3. The width at 5 M
urea was greater than it was at both lower and
β-Lactoglobulin Assembly into Amyloid
1335
Fig. 2. AFM images of β-LGa
aggregation under amyloidogenic
conditions. Days 10, 22, 29, and 65
are shown as labeled. Images are
colored by height and approximately correspond to species
described in the text. AFM heights
are uncorrected for tip penetration
of the soft samples. Prior to day 10,
there was little indication of stable
aggregates adhering to aminosilanized mica surface. The first sign of
small stable oligomers (in green)
appears on day 10. The total number and aspect ratio of the aggregates increase through day 22. After
4 weeks, small protofibrillar species
are apparent and range from 50 nm
to several hundred nanometers in
length. Fibrillar species ranging in
height and length dominate at
2 months of incubation. Large
amorphous aggregates appear as
early as day 10, but appear to be off
the amyloid formation pathway.
higher urea concentrations, where the protein is a
native monomer (2.5 M) and is unfolded (7.5 M),
respectively. This was consistent with literature
reports that at 5 M at neutral pH, β-LGa intermediate and denatured states are in thermal
equilibrium.76 From days 0 to 2, the position of the
peak maximum moved from the monomer decay
time to the dimer decay time. By day 4 of incubation,
the peak maximum has moved to the position
expected for the tetramer decay time.
Figure 4 shows the evolution of the DLS decay
time distribution taken every 2 days for the first
28 days of incubation. The 0- to 4-day evolution
matches that of Fig. 4. The peak maximum of the
small aggregate region did not substantially change
after day 4. The peak width was broader than
expected for a monodisperse tetrameric aggregate.
From days 10 to 18, a shoulder appears (Fig. 4) to
lengthen decay times, suggesting the growth of a
minority species of larger aggregates. A weak and
Fig. 3. GIPG fit of DLS correlation functions for the 4.7-day
incubation of β-LGa. A continuous-acquisition DLS experiment
allowed investigation of the earliest
aggregation events. During the first
hour of incubation, the hydrodynamic radius of β-LGa was consistent with a partially unfolded
monomer at 2.5 nm [shown as a
brown mesh line (1)]. If the aggregation preserves the density, the
decay times of approximately
spherical dimeric and tetrameric
species can be calculated; they
are represented by the green (2)
and blue (4) mesh lines, respectively. The monomer was converted to mostly dimer by day 2, then to tetramer by
day 4.
1336
β-Lactoglobulin Assembly into Amyloid
Fig. 4. GIPG fit of DLS correlation functions for the 28-day incubation of β-LGa. Mesh lines (1)
and (4) are the same as in Fig. 3.
The high-resolution DLS fits coincide with the first few days of
the 28-day incubation. A shoulder
appeared on day 10 and separated
from the tetramer species on day
18 (orange dashed contour). This
feature has a decay time characteristic of a small inflexible rod with
length ranging from 15 to 30 nm,
with the same radius as the tetramer. The red, orange, and green
bars represent a rough estimate of
the early, middle, and late phases
that we have consistently observed
throughout our experiments. The white mesh line demarcates the intensity and number-weighted representation of the
decay times, allowing the entire data set to be presented together.
broad peak grows slowly from days 12 to 18 at
∼ 1.5 ms and becomes appreciable from days 18 to
28. At these later stages, the large distribution of
particle sizes and shapes prevents specification of
these quantities in terms of the ensemble-averaged
DLS decay time distribution.
Interpretation
The DLS data suggest three phases of aggregation. Aggregation of the monomer proceeded
rapidly within the first few days of incubation.
Nonreducing SDS-PAGE analysis after 5 days of
incubation showed mainly disulfide-linked dimers
with some monomers. The motility of the monomers that were still present was consistent with
their native disulfides still being intact. This
suggests that oxidative aggregation does not exceed
the dimeric state, consistent with only a single
exchanging cysteine per monomer. Upon accumulation of the approximately tetrameric aggregate, a
new phase begins. Further changes showing
increases in particle size appeared during days
10–18, suggesting another mode of aggregation.
The contribution of these particles to the DLS signal
eventually was swamped by the contribution of the
large particles that appeared in significant numbers
from day 18 onward. Late-stage (N 30 days of
incubation) SDS-PAGE showed similar results,
with the concentration of the dimers being about
50% that of the monomers. Again, the motility of
the monomers was greater under the nonreducing
conditions than under reducing conditions. The
lack of disulfide cross-linked aggregates of higher
order than dimers at late stages is consistent with
higher-order aggregation being associated with
non-covalent interactions.
ThT tracks structural conversions
We used a ThT assay to evaluate the point in the
incubation when the aggregates converted into
amyloid. Steady-state luminescence measured during incubation shows the classic sigmoid curve that
is often associated with amyloid formation. As seen
in Fig. 5, the individual lifetime contributions to the
signal, however, have a very different behavior.
When measured in buffer, ThT shows four
contributions to the lifetime distribution, and we
speculate that the different lifetimes arise from
different ThT aggregate geometries that are free in
solution.71 ThT in the presence of unincubated βLGa shows an additional lifetime contribution at
∼ 110 ps that is not present in the protein-free
control. β-LGa is known to bind hydrophobic
molecules; therefore, some luminescence changes
associated with this binding to the monomer are
expected. It is also possible that a single β-LGa could
bind two ThT molecules, creating a small amount of
dimer signal, as was shown by intercalation of ThT
in γ-cyclodextrin.72,73
The ThT lifetime distribution was substantially
different at each phase of the incubation. During the
beginning of the lag phase (days 0–5), we saw a
decrease in the contributions that are present in the
ThT-only control. The relative contributions of these
components also change. This behavior suggests
that the aggregation in the early lag phase reduces
the solution-phase portion of the ThT in favor of
protein-partitioned ThT. During the lag phase (days
9–18), we saw a different pattern emerge in the
lifetime distribution. Several new lifetime features
ranging from 75 ps to 2.2 ns appeared.
After day 18, the distribution began to change
rapidly, as shown by the growth of a feature at
2.6 ns, followed by a feature at 1.3 ns. On day 32, the
majority of the luminescence signal came from the
580-ps lifetime. The short-lifetime feature at 11 ps
disappeared and was replaced by a feature at 18 ps
that attained a maximum at 26 days and then
disappeared by 33 days. After 2 months of incubation, the distribution was dominated by a broad
asymmetric peak at 2.6 ns, with a smaller contribution at 250 ps.
β-Lactoglobulin Assembly into Amyloid
1337
Fig. 5. GIPG fit of ThT luminescence decays in the presence of β-LGa over a 28-day incubation. Left panel: The
evolution of lifetime distributions shows that the onset of luminescent species occurs in stages. The reduced chi-square
(χ2r) value for this global fit was 1.022. Right panel: Incubation time slices of ThT lifetime distributions with different
contributions on days 0, 5, 16, 32, and 65 are as labeled and correspond to the dotted mesh lines in the right panel. To
depict the growth and loss of different luminescence components along the incubation time course, the distributions are
filled to the baseline with colors corresponding to the trace where the particular component dominates. For example, the
green filling matches the peaks on day 32, but the same components are less prevalent on day 16.
There are clearly multiple contributions to the
ThT lifetime distribution. Each phase of the incubation has a distinct lifetime distribution, suggesting
that ThT associates with many different aggregates
in structurally different ways. We observed that
significant ThT luminescence grew during the
earliest stages of incubation (Fig. 5). These changes
in an intensity-only experiment might be interpreted as a baseline shift. The association of
monomers into a disordered aggregate may provide
ThT the opportunity to form dimers that show
luminescence similar to that of amyloid; however,
the lack of regular geometry results in a different
lifetime. Particularly striking is the difference
between the 580-ps contribution that seems to
appear in association with protofibrils and the 2.6ns contribution that appears in the late-stage
aggregation where mature amyloid fibrils are
present. The signal from ThT that is usually
associated with histological staining is probably
most closely related to the distribution from the 65day sample. The ThT signal changes that contribute
to the classic sigmoidal intensity kinetic trace are
most likely due to other binding modes and
luminescence lifetimes. This suggests that the
proamyloid ThT luminescence has a structural
sensitivity that is reflected in its luminescence
lifetime distribution. ThT assays based only upon
intensity could be misleading, since there are
several contributions to the luminescence that are
potentially changing during incubation. The contributions from the different species cannot be
resolved from intensity alone.
ANS reports changes in hydrophobic regions
and calyx loss
The fluorescence lifetime of ANS was measured
during 28 days of amyloidogenic incubation. We
used GIPG as a model-free approach to determine
the evolution of the ANS fluorescence assay lifetime
distribution. We observed several peaks in the
distribution that change systematically with incubation time and labeled them (a) though (i) for clarity,
as shown in Fig. 6. Some of these peaks change
during the first several days of the incubation.
Others grow at the late stages of the incubation. The
evolution of individual peaks can be associated with
the changes in the availability of specific binding
environments on β-LGa in its various aggregation
states. To directly evaluate the evolution of the
contributions from each subpopulation of ANS, we
constructed a reduced-basis set representing each
peak from the original GIPG fit as a separate
function. The Laplace transform of each of these
peaks was convoluted by the instrument response
function in this simplified basis set. The population
of each contribution as a function of incubation
time appears in Fig. 7. These subpopulations of
ANS binding were then assembled into lifetime
1338
β-Lactoglobulin Assembly into Amyloid
Fig. 6. GIPG fit of ANS fluorescence decays in the presence of βLGa over a 28-day incubation. The
χ2r for this global fit was 1.019. The
distribution of fluorescence lifetimes showed the variety of binding
environments for ANS and their
systematic population changes
with incubation time. The reduction of some peaks (i.e., a, b, and c)
and the increase of others (i.e., g, h,
and i) reflected the conformational
changes experienced by β-LGa as it
assembles into fibrils. All peaks are
assigned to different ANS environments in the text. This model-free
fit was used as the basis for further
data reduction as described in the
text and as shown in Fig. 7.
distribution fingerprints for the different species
along the amyloid-formation pathway.
ANS is quenched by full exposure to 5 M urea and
gave a lifetime of ∼ 300 ps (e) in our control
experiments. This contribution appeared to decrease
as the incubation progressed. This suggested an
increase in the partitioning of ANS with the protein
as compared to the solution and was consistent with
an overall increase in the availability of hydrophobic
binding sites as the incubation proceeded.
The model-free GIPG fit in Fig. 6 shows an 89-ps
feature (f), which was also present in the ANS
lifetime distribution from 1 to 6 M urea in our
control experiments, but only when β-LGa was also
present. This feature appeared to increase in
population from days 0 to 14, then to decrease
from days 16 to 28. The 89-ps contribution overlapped with a broad lifetime contribution at 70 ps (j)
that grew starting on day 18. The increase in this
contribution appeared to compensate for the loss of
the 89-ps contribution. These lifetimes were significantly shorter than that of the free ANS,
suggesting a quenching interaction with an amino
acid side chain.
The monomeric signal included contributions
from peaks at 18.2 ns (a), 7.9 ns (b), and 2.7 ns (c).
The peak at 18.2 ns was close to the unquenched
lifetime of ∼ 19 ns predicted by an evaluation
of oscillator strength using the Strickler–Berg
equation.77 This suggested that ANS was sequestered from any quencher and was protected from
water, consistent with an intact calyx. This feature
decreased throughout the incubation. ANS can
induce structure in proteins, and the presence of
folded β-LGa under these conditions may be a
result of this effect. No other lifetime feature in the
distribution appears to compensate for the loss of
the 18.2-ns feature.
The peak at 7.9 ns (b) also suggested protection
from water, although to a lesser degree. This was
consistent with a partially denatured calyx. The 7.9ns feature decreased dramatically in the first 8 days,
leveling off until day 18, whereupon it continued to
decrease. The changes in the 7.9-ns contribution
appeared to be mostly compensated for by changes
in a feature at 4.9 ns (h). The highly anticorrelated
behavior of the 7.9- and 4.9-ns components suggested that the 4.9-ns feature was from ANS bound
to β-LGa that had its 7.9-ns calyx site disrupted by
aggregation.
The peak at 2.7 ns (c) has been previously
attributed to β-LGa surface binding.76 Based on
our ANS docking studies, we found that the mouth
of the calyx is a more likely assignment for this
feature. The 2.7-ns feature decreased rapidly at first,
with its evolution slowing after 8 days and accelerating again during the late stages of incubation.
The 2.7-ns feature population changes were partly
compensated for by changes in the 2.1-ns feature (i).
Again, this close relationship leads us to conclude
that the mouth of the calyx is disrupted during the
process that exchanges the population of the 2.7and 2.1-ns features.
Overall, the changes in the ANS lifetime distributions occurring after day 20 were more dramatic.
One of these was an 11-ns feature (g) that appeared
to grow at the late stages of incubation. The long
lifetime suggests that ANS was mostly isolated from
water. We attribute it to sequestration of ANS in the
cross-β structure of amyloid protofibrils.
Not all of the lifetime features changed over the
incubation time course. The feature at 790 ps (d) was
present throughout the incubation, with only small
changes in intensity. Therefore, the 790-ps site
should be a structure that was not disrupted in the
aggregation process. This lifetime was consistent
with surface binding, which should be present at all
points of the incubation. The 790-ps lifetime
appeared to shift slightly at different points in the
fits presented in Fig. 6. These shifts were too small to
reliably resolve multiple lifetime contributions to
this feature.
Any particular ANS lifetime peak can, in principle, contribute to several different aggregates. As
reflected in the lifetime, the binding location, but not
the specific aggregation state, is sensitive to the local
β-Lactoglobulin Assembly into Amyloid
1339
the various monomeric and monomer-like components. It was assigned from the day 0 β-LGa urea
titration control experiments. The monomer fingerprint was subtracted from the day 8 reduced-basis
GIPG lifetime distribution at a level that maintained
nonnegativity of the distribution to obtain a
difference fingerprint. We assumed that this difference fingerprint was due to an early oligomeric
species that we designated “aggregate A” (AggA).
The first two fingerprints were removed from the
day 16 distribution to obtain a fingerprint that we
designated “aggregate B” (AggB). The first three
fingerprints were removed from the final distribution to obtain the fingerprint for “protofibrils.”
Fingerprints for the unbound ANS at 300 ps (e)
and the surface ANS at 750 ps (d) were included
separately into the fits. These fingerprints appear in
Fig. 8. The rationale for the designations of the
different fingerprints is in the Discussion.
Specific differences in the contributions of the
different ANS lifetime peaks can be noted for the
different fingerprints. The monomer fingerprint had
a ratio [7.9 ns (b) and 2.9 ns (c)] different from that of
AggA, which also lacks the 18-ns contribution (a).
The contribution from the 89-ps peak (f) increased in
the AggA fingerprint, which also had a new
contribution at 4.9 ns (h). The AggB fingerprint is
Fig. 7. Subpopulations of ANS binding to β-LGa over
a 28-day incubation using GIPG with a reduced basis set.
The χ2r for this global fit was 1.020. In the top three panels,
the red squares represent decreasing lifetimes, and the
blue triangles represent increasing lifetimes corresponding to the subpopulations in Fig. 6. The species lifetime
evolutions are associated with a change in the ANS
environment in the calyx or surface sites. The bottom
panel shows the trends of the short lifetime components.
(a) through (i) match the peaks in Fig. 6. The red and
orange dotted vertical lines mark the lifetime components
on days 8 and 16, which were combined with those on
days 0 and 28 to generate the characteristic “fingerprints”
of the ANS-bound protein species and are shown in Fig. 8.
environment. Nevertheless, the relative contribution
of each binding site to a particular aggregate should
be in some fixed proportion that depends on the
structure of the β-LGa monomers in it. During
amyloidogenic incubation, we see three main phases
in the kinetic evolution of the ANS lifetime
distribution that are corroborated by other experiments. We seek to separate the contributions of at
least four species with qualitatively different aggregation states.
We assumed that the contributions of different
species could be expressed as linear combinations of
a multipeaked “fingerprint” describing both the
relative binding likelihood and the nature of the
various binding modes of ANS in each species. The
first fingerprint describes the lifetime distribution of
Fig. 8. The characteristic “fingerprint” lifetime distributions of ANS-bound β-LGa. The evolution of the ANS
lifetime distributions was decomposed into “fingerprint”
for each species. The fingerprints are labeled in the figure
and used to fit the TCSPC decays with GIPG.
1340
Fig. 9. The evolution of each fingerprint's contribution
to the ANS β-LGa fluorescence decays. The χ2r for the
global fit was 1.026. The evolution of the monomer, AggA,
AggB, and protofibril showed multiple stages of aggregation. The monomeric species decreased dramatically in the
first several days and is consistent with the DLS fits shown
in Fig. 3. The increase in AggB from days 10 to 22 matched
the accumulation of stable round aggregates in the AFM
results. The increase in the number of protofibril species
after day 24 coincided with significant changes in the ThT
lifetime distributions and rodlike particles imaged by
AFM.
missing the 7.9- and 4.9-ns components, and gained
a new contribution at 2.1 ns (i). The protofibril
fingerprint gains a peak at 11 ns (g) and trades the
89-ps contribution for the 70-ps feature (j). If a
particular aggregation step does not result in a
structural change, then it will not be reflected in
the fingerprint or in the fingerprint population
evolution.
Each fingerprint generated a single instrument
response convoluted basis function for use in the
GIPG fit. The resulting evolution of the population
of the fingerprints appears in Fig. 9. The population
of the monomer fingerprint appeared to decrease
rapidly during the first 4 days of incubation. This
contribution plateaued around day 8 and began to
β-Lactoglobulin Assembly into Amyloid
decrease again after day 24. The AggA fingerprint
grew as the monomer disappeared and reached a
maximum value on day 10. It then slowly decreased
until day 18, after which it decreased more rapidly.
The AggB fingerprint grew slowly beginning on day
6, pausing from days 12 to 16, after which it
increased more rapidly, reaching a peak on day 24.
The protofibril fingerprint was flat for the first
20 days of incubation, after which rapid growth
occurred.
The evolution of the individual peak fits and
fingerprints suggested three phases to the aggregation process: (1) the monomer converted to AggA,
(2) then AggA converted into AggB, and (3)
protofibrils began to appear after AggB had formed
in large quantities.
ANS aggregation reversibility assay
One of the classic features of amyloid is its
stability with respect to dissociation. To evaluate
the amount of stabilization in different aggregates,
we performed the ANS assay under conditions of
0.5 M urea concentration following incubation at
5 M urea. Under these conditions, unfolded
monomers are expected to spontaneously refold.
If the stabilization energy of the aggregate is greater
than that of the refolding reaction, then the
aggregation will not be reversible upon dilution
of the denaturant.
The GIPG fit to the ANS aggregation reversibility
assay data appears in Fig. 10. The nearly constant
amplitude peak at 240 ps is consistent with free ANS
in 0.5 M urea. This peak increases in amplitude
during the first 5 days of incubation, decreases
slightly until day 9, and then increases again, with
the increase accelerating after day 14.
On day 0, the peak associated with surface
binding at 830 ps did not appear at its 0.5 M control
experiment position, suggesting that the association
at this site was somewhat irreversible. From days 2
to 8, the peak was shifted to its reversible position
at 1.1 ns; from days 10 to 18, it shifted to 790 ps.
This result may indicate that there was a kinetic
Fig. 10. GIPG fit for the ANS
reversibility assay. The stability of
the monomer and aggregate species
is evaluated by reintroducing the
incubated sample to a low-urea condition. Yellow mesh lines demarcate
3.6, 4.3, 13, and 16 ns to emphasize
the loss–gain of species more
clearly. The most dramatic feature
is the nearly 50% loss of the 16-ns
species, presumably the calyxbound ANS, by day 8. The loss
contemporaneously matches the
change from the 4.3- to the 3.6-ns
species. The χ2r for the global fit
was 1.002.
1341
β-Lactoglobulin Assembly into Amyloid
competition between refolding of the surface site
(perhaps at the α-helix) and binding of ANS. If this
is the case, it would suggest that, during days 2–8,
the binding site was protected from ANS until after
refolding had occurred. The overall amplitude of
this peak did not change much, consistent with the
results of the standard ANS assay.
The peak at 16 ns was consistent with binding to
the calyx; it decreased rapidly from days 0 to 4 and
continued to decrease more slowly from days 6 to
12. This peak was replaced by a feature at 14 ns that
appeared around day 1, increased until day 14, and
decreased thereafter. Around day 18, the peak
shifted to 13 ns. The rapid decrease in the
availability of the calyx suggests that the aggregates
in the early stages prevented the binding of ANS to
the calyx. The shifts in lifetime suggest that although
some structure resembling a calyx can reform as late
as day 18, the population of these proteins is
substantially reduced and they cannot reform the
full calyx that is possible before aggregation has
occurred.
We attributed the peak at 4.3 ns to the outer calyx
binding site. This lifetime was shorter than the 5.4-ns
lifetime that we determined from the 0.5 M control
measurement. This suggests a degree of irreversibility even on day 0 in this binding site. This feature
decreased from days 0 to 4, leveled out from days 5
to 8, and then decayed away from days 8 to 12. This
feature was replaced by a peak at 3.6 ns that
increased until day 12, after which it remained
steady from 14 to 18 days. Overall, the qualitative
behavior of this feature was similar to the feature at
16 ns.
There were essentially three manifestations of
irreversibility represented in these data. The first
was the ability of the protein to regain the same ANS
binding sites after dilution from 5 to 0.5 M urea, as
determined by the lifetime distribution. The dilution
was performed in the presence of ANS. If the ANS
binds to the site in question prior to refolding, then it
could lock the protein into a misfolded conformation at the binding site. The result is a lifetime that
more closely resembles the 5 M urea control
experiment conditions than the 0.5 M urea conditions. The second type of irreversibility was the loss
of a particular binding site as aggregation progressed. This suggests that the aggregate disrupts or
blocks access to the site in question and that the site
cannot be reformed by dilution of the denaturant.
The third type of irreversibility was the replacement
of one site with another. This is similar to the second
type of irreversibility, except that the structural
change has resulted in a new local environment for
the binding of ANS.
These three types of irreversibility suggest that
there are two main stages to the incubation over the
range of 0–18 days that appear to transition at 8–
10 days. The changes that were reflected in the
irreversibility suggested that one of the key elements
distinguishing the different aggregation steps was
the reversibility of the interactions between monomers in the different aggregates.
Discussion
Conformational lability prior to incubation
Our results suggest that β-LGa was conformationally labile under the amyloidogenic incubation
conditions. The ThT assay showed little change in
signal over the protein-free control, except for an
additional peak at 110 ps. The ANS assay showed
several lifetime components and a substantial
contribution from intact calyx binding of ANS,
suggesting that ANS may be stabilizing the folded
structure.78 The multiplicity of features in the 5 M
urea ANS assay suggested multiple structures for
monomeric β-LGa. In particular, the calyx or
hydrophobic core was more flexible and more
accessible to solvent, as shown by ANS fluorescence.
The reversibility ANS assay showed minor signs of
irreversibility and fewer lifetime features. Under
these conditions, β-LGa adsorbed on an aminosilanized mica surface and appeared to be denatured.
The DLS measurements showed that the protein
had swelled and had a broad distribution of
hydrodynamic radius. In a titration from 0 to 7 M
urea, the width of the DLS RH distribution was
broadest at 5 M urea. That the width of the
distribution is resolvable implied that the exchange
time within that distribution was longer than the
characteristic diffusion time of ∼ 20 μs. Amyloid
formation from β-LGa has been observed to be
fastest at 5 M urea.13 The day 0 DLS results showed
that the conditions giving the maximum rate of
amyloidogenesis were coincident with those that
created the maximum variance in the hydrodynamic
radius of β-LGa.
Overall, we can conclude that there are multiple
monomeric structures exchanging in the sample
under these conditions. The partially folded intermediate appeared to be the aggregation-prone state.
The ability to exchange between multiple conformations may be a crucial feature in determining
aggregation propensity. To use free-energy landscape language, the folding funnel flattens, allowing
access to disordered states of increased RH and core
solvation.
Early lag-phase aggregation was more reversible
The DLS assay showed that aggregation occurs in
the first few days of incubation, with average
particle sizes passing through a dimeric stage to a
steady state with an average size consistent with
that of tetramers. In the AFM assay, the aggregates
could be imaged on a clean mica surface; however,
on a more strongly adsorbing aminosilanized mica
surface, the aggregates were disrupted and denatured on the surface. The ANS 5 M urea assay
revealed a decreased ability of ANS to bind to the
calyx. The irreversibility assay showed changes
predominantly in the calyx binding site. The
fingerprint analysis of the ANS 5 M urea assay
suggested that a new species was growing, with a
1342
small contribution from another species. We call
these species AggA and AggB, respectively. The
differences in fingerprints suggested changes in the
nature and relative populations of different binding
sites and, therefore, a change in the tertiary structure
of the monomers upon aggregation. However, the
ThT assay only showed small changes in lifetime
distribution, implying that this structural change
did not occur in the cross-β structure associated
with amyloid.
The stabilization energy of AggA was less than the
electrostatic interaction with the aminosilanized
mica surface. However, AggA was not disrupted
by dilution into more native-like conditions, suggesting that the AggA stabilization energy was
between the folding energy and the surface adsorption energy. The interaction between monomers in
AggA most likely involved some change or disruption of the calyx that allowed solvent access. Some
parts of the structural changes that occurred upon
AggA formation were still reversible at this stage.
This suggested that the structure of β-LGa in AggA
more closely resembled the free monomer than did
AggB. AggA appeared to be limited in total size.
Continued growth most likely required disruption
of the remaining free-monomer-like structure. AggA
in Fig. 11 was modeled with swapping of structural
β-Lactoglobulin Assembly into Amyloid
elements. This type of interaction is possible because
of the inherent self-complimentary nature of folded
proteins. These interactions are also likely to
sterically limit the maximum size of aggregates
that could be so assembled.
Late lag-phase aggregation loses calyx
During the late lag phase, small aggregates could
be possibly imaged on the aminosilanized mica
surface. In the DLS assay, the appearance of a wing
on the distribution to larger RH and the growth of a
new feature at large RH suggest that aggregate
growth resumes during this stage. The ThT assay
shows a new pattern in the lifetime distribution. The
ANS fingerprint analysis showed that AggB begins
to get appreciable population, while AggA decreases
in population, suggesting a conversion from AggA
to AggB. The ANS irreversibility assay showed that
AggB had new binding sites for ANS. This suggested
that the structural conversion was inside of the
aggregate, rather than a newly formed aggregate.
Conversion to AggB appeared to be required for
growth to continue. The stability of AggB with
respect to dissociation on the aminosilanized surface
implied that it was more stable than AggA. AggB
was larger, on average, than AggA. The monomer
Fig. 11. Proposed mechanism of β-LGa aggregation. Amyloidogenic conditions put β-LGa into a disordered,
conformationally labile state that reversibly aggregates into dimers and tetramers that are stabilized in part by
hydrophobic interactions. The calyx is intact but structurally altered. As aggregation continues, the calyx is lost, and the
loosely associated oligomers convert into higher-order more stable aggregates. These aggregates then convert into
protofibrils that elongate in the classic growth phase of sigmoidal kinetics. Monomeric: The top is the folded monomer;
the middle was obtained by modeling the unfolding of the C-terminal α-helix and β-strand I. The bottom was obtained by
flattening the barrel into a sheet. AggA: These oligomers were obtained by aligning complementary surfaces of the middle
monomer structure. Aggregate B: This octamer was modeled by stacking the flattened monomer structure into four
layers. Protofibrils: Four sheets of the canonical cross-β structure.
β-Lactoglobulin Assembly into Amyloid
structure changed from AggA to AggB, as reflected
in the changes in the ANS assay binding sites. AggB
was also structurally different from AggA in terms
of the monomer–monomer interactions, as suggested by the ANS reversibility assay. The changes
in AggB structure allowed ThT–ThT interactions
that were not possible in AggA. The ThT assay
implied that some elements of the AggB structure
might be similar to those in amyloid fibril. However,
no fibrils or protofibrils were observed at this stage.
The ThT lifetime contributions of fibrillar species
were different from those of AggB. Conversion into
AggB could be misinterpreted as amyloid formation
if only changes in ThT intensity were measured.
Protofibrils appear after day 20
During the growth phase, the light-scattering
intensity increased enormously and the amount of
large aggregate increased. AFM images showed the
appearance of protofibrils followed by elongation of
protofibrils and, finally, fibril assembly into long
fibrils of varying lengths and diameters. The ANS
assay showed dramatic growth in the protofibril
fingerprint, a decrease in the AggA fingerprint, and
a steady state for the AggB fingerprint. At very long
incubation times, very little ANS binding to mature
fibrils was observed, suggesting the presence of
accessible hydrophobic regions on the protofibrils
that disappeared upon formation of mature fibrils.
We speculate that these hydrophobic locations are
involved in the lateral association of protofibrils into
fibrils. The ThT assay showed a new lifetime
distribution pattern that continued to grow until at
least day 34. We associated this pattern with
amyloid protofibrils, since the distribution was still
very different from that observed from mature
fibrils. Only some of the protofibril features were
present in the ThT assay (where mature fibrils were
present) taken after 2 months of incubation. A large
ThT lifetime contribution that was not present at any
other stage was present in the mature fibril data. The
structure of protofibrils at the ThT binding level
must be different from that of fibrils.
Overall mechanism
The native β-strands in β-LGa are not in the right
orientation to attain the cross-β geometry. It appears
likely that an interaction analogous to domain
swapping or opening of the β-sheet “sandwich”
would be required for β-LGa to associate with the
cross-β geometry. Based on the observed morphology of amyloid fibrils and the size of β-LGa, it
would require approximately two to three β-LGa
monomers, or four to six flattened monomers, to
form the transverse structure of a 4- to 5-nmdiameter fibril. A fibril ∼ 45 nm long would contain
∼ 32 β-LGa monomers and would have a total
molecular mass of 590 kDa. A fully formed amyloid
fibril of 10 nm × 200 nm would contain ∼ 700 β-LGa
monomers and would have a total molecular mass
of 12.9 MDa.
1343
Our results suggest that there are two parts to the
lag phase of β-LGa amyloid formation. The
sequence of events is similar to some recent kinetic
analyses of amyloid nucleation.22 We monitored the
role of the hydrophobic core using the signature
lifetime of ANS in the calyx. We showed how
fluorescence lifetime fingerprints can be used to
extract the contribution of multiple species during
incubation. We identified two intermediates in the
lag phase that are distinguishable by their relative
stability, size, and binding of ThT and ANS. ANS is
sensitive to the rigidity and polarity of binding
locations, while ThT is sensitive to the relative
geometry of its ThT binding sites. Based on this
information, we must conclude that significant
rearrangement of structure must occur between
AggA and AggB. The standard interpretation of
this change would be that AggB represents the
conversion into the amyloid nucleus. However, ThT
gave different signals when bound to AggA, AggB,
and protofibrils. Moreover, the onset of the rapid
growth of protofibrils does not occur until many
days after the appearance of AggB. Therefore, we
must conclude that AggB is distinct in structure
from both AggA and protofibrils. The presence of
multiple aggregated species in a serial mechanism
suggests that homogenous nucleation may not
be a universal description of amyloid formation
kinetics.
The initial aggregation into AggA and the
subsequent aggregation into AggB must have
some driving force associated with them. Two
simple models—colloidal aggregation and polymer
phase stability—can be invoked to frame the initial
aggregation. The inherent hydrophobicity of the
polypeptide chain can lead to an aggregated phase
of protein being more stable.16 The driving force in
this case is the increased number of favorable
protein–protein and water–water contacts and a
decreased number of protein–water contacts. Colloidal aggregation is similar, except that it attributes
the driving force to the partitioning of amino acids
with unfavorable protein–water contact energies
into a region of higher protein–protein contacts,
while amino acids with favorable protein–water
contact energies are partitioned into the surface of
the aggregate. This partitioning puts an additional
geometric constraint on the aggregation process that
is not present in the phase-stability picture.
Given the large number of charged amino acids on
β-LGa, we favor the colloidal aggregation picture;
however, our data only indirectly address this issue.
Colloidal association in AggA and then in AggB
could reduce the barrier to the conformational
change in cross-β required to form amyloid.
Colloidal association is required because the monomer cannot rearrange without sacrificing a prohibitively large number of hydrophobic interactions. If
the protein has a strong hydrophobic core, then the
hydrophobic effect is too strong to disrupt. If the
protein is completely unfolded, the possible hydrophobic gains are too weak to overcome the translational entropy that is lost to aggregation.
1344
There is a connection to protein folding in this
analysis. Proteins below a certain size typically
cannot fold stably. This can be attributed to the
absence of a large enough number of favorable
interactions to meet the thermodynamic conditions
of cooperativity. By associating with colloidal or
phase-separated aggregates, the protein increases its
effective molecular weight and potential number of
favorable interactions to the point where the fold of
amyloid is accessible. This colloidal or phaseseparated promotion of conformational rearrangement may explain the ability of surfactants to
promote amyloid formation.
Amyloidogenic conditions have been identified
for many non-disease-related proteins. This leads to
the hypothesis that aggregation of proteins leading
to amyloid fibril formation is a generic feature of
polypeptides.7,79 If the hypothesis that amyloidogenesis is a generic possibility for proteins is valid,
then we should think about amyloid as a particular
state of protein in the polypeptide phase diagram.
The driving forces for phase separation into amyloid
should depend on the relative contributions of
hydrogen bonding to the cross-β structure and the
arrangement of hydrophobic groups. There is
evidence that the polypeptide is hydrophobic from
a polymer physics point of view, i.e., that polymer–
polymer contacts are more energetically favorable
than polymer–water contacts.80,81 This would suggest that the environmental and sequence determinants for amyloid propensity are more based on the
lowering of the barrier to formation of the amyloid
phase than on the stability of the amyloid phase
itself. In other words, the effects are principally
kinetic rather than thermodynamic. In particular, in
this study, we propose that the initial aggregation to
AggA allows a larger hydrophobic core to be
formed in AggB. This allows the cross-β structure
to be obtained in the protofibril. The initial
bistability of the monomer allows formation of
AggA. AggA allows a lower-barrier pathway to
the formation of AggB, which is large enough to
rearrange into the more stable cross-β structure
without a prohibitively large activation barrier. This
allows the spontaneous formation of amyloid protofibrils to occur even when barriers to the formation
of the cross-β structure directly from the monomer
or even AggA are energetically prohibitive.
Materials and Methods
Materials
Lyophilized β-LGa, ThT, urea, aminopropyltriethoxysilane (APTES), and dibasic and monobasic sodium phosphate were purchased from Sigma. Fluorescence-grade
ANS was purchased from Fluka.
A 10 mM sodium phosphate (pH 7.0) stock buffer
solution was prepared with HPLC-grade water. This
buffer was used to prepare a second stock buffer containing 7.5 M urea. Both stock buffers were filtered through a
0.22-μm polyethersulfone filter and stored at 4 °C. For DLS
β-Lactoglobulin Assembly into Amyloid
measurements, extra care was taken to minimize scattering from dust contaminants by filtering stock buffer
solutions with a prewashed 0.020-μm syringe filter
(Whatman). The 0 M urea stock phosphate buffer was
used to prepare a 138 μM stock protein solution of β-LGa,
which was stored at 4 °C. The protein stock solution was
checked by UV absorption every few days to ensure its
stability.
β-LGa incubations
We incubated β-LGa under conditions previously
reported to show maximum amyloidogenicity,13 and we
aliquoted samples for time-resolved ANS and ThT
luminescence, DLS, and AFM experiments.
For time-resolved luminescence and DLS measurements, 1.5 mL of protein sample for incubation was
prepared every other day for 28 days and used for ANS
assay along with the long-term DLS experiments. For ThT
and ANS reversibility assay, samples were prepared every
day for 34 days and 18 days, respectively. Each incubation
sample was prepared by combining a 500-μL aliquot of
the stock protein solution with 1000 μL of the 7.5 M urea
stock solution in a polypropylene Eppendorf tube,
resulting in a final protein concentration of 46 μM and a
final urea concentration of 5 M. The sample was capped,
sealed with Parafilm, and placed in an incubator at 37 °C.
At the conclusion of the incubation, all samples were
breached and each was parsed for contemporaneous
experimentation.
To investigate the earliest aggregation with DLS, a
sample of 46 μM β-LGa in 5 M urea and 10 mM sodium
phosphate (pH 7.0) was prepared from the stock solutions
above. The sample filled the cuvette to approximately 90%
capacity in order to reduce the sample headspace. DLS
was measured while simultaneously incubated at 37 °C
in a Peltier sample chamber (instrumentation discussed
below).
For the AFM measurements, lyophilized β-LGa was
reconstituted and dialyzed against prefiltered (0.22 μm)
100 mM phosphate buffer (pH 7.0). Prefiltered concentrated urea buffer was added, which resulted in a final
sample condition for incubation of 50 μM protein in 5 M
urea and 13.7 mM sodium phosphate (pH 7.0). The sample
was incubated in a Parafilm-sealed 1.5-mL Eppendorf
tube at 37 °C over 65 days. The sample was inverted once
on each day that AFM was measured, and 20 μL was
aliquoted for the AFM image.
Time-resolved luminescence
Time-resolved luminescence was measured by timecorrelated single-photon counting (TCSPC). The Experimental setup has been previously described,82 with the
exception that the Spectra Physics Tsunami Ti:Sapphire
laser was operated in femtosecond mode. All samples
were analyzed at 37 °C in a Quantum Northwest
(Spokane, WA) TLC150 Peltier controller sample chamber.
For the ThT assay, a stock 5 μM ThT solution was
prepared from the 0 M urea stock buffer. Fifty microliters
of an incubated time point was aliquoted into 450 μL of
ThT solution in a reduced volume cuvette and allowed to
stand for 15 min at 37 °C. The excitation laser was tuned to
450 nm, and the luminescence was observed at 482 nm.
The time-zero intensity ranged between 30,000 and 60,000
photons. A 50-ns collection window was used. Instrument
response functions typically had a full width at halfmaximum of approximately 90 ps.
1345
β-Lactoglobulin Assembly into Amyloid
An 80 μM ANS stock solution was prepared in a 0 M urea
stock buffer for the ANS assay. Five hundred microliters of
an incubated time point was combined with 10 μL of the
ANS stock solution and allowed to stand for 15 min at 37 °C.
For the ANS reversibility assay, a 1 μM ANS stock
solution was prepared in a 0 M urea stock buffer. Fifty
microliters of an incubated time point was combined with
450 μL of the ANS stock solution and allowed to stand for
15 min at 37 °C. Excitation beam was tuned to 390 nm, and
the fluorescence emission was observed at 485 nm over
100- and 82-ns collection windows for the ANS and ANS
reversibility assays, respectively. A typical transient's timezero intensity was 4000 photons for the ANS reversibility
assay, whereas an intensity of 18,000 photons was common
for the ANS assay. Instrument response functions typically
had a full width at half-maximum of approximately 100 ps.
We expect the population of the luminescent species to be
piecewise continuous with respect to incubation time,
making this system a prime candidate for global data
analysis by the GIPG method.64,82 ThT luminescence
lifetime distributions were fitted on an 80-point grid,
logarithmically spaced in lifetime ranging from 0.002 to
20 ns. Both types of ANS assays were fitted on their own 58point grid, logarithmically spaced in lifetime ranging from
0.03 to 30 ns. A baseline and scattering term was included in
the fits. To compensate for potential incident laser intensity
fluctuations across incubation time, all TCSPC transients
were normalized by the total time-zero photon population.
This is accomplished by summing the parameters from a
nonnegative least squares fit.64,83 The GIPG fits were
considered statistically indistinguishable from the local fits
by calculating the probability to reject64,84 to be b 10− 4 for all
fits. ThT, ANS, and ANS reversibility assays of GIPG fits
used 8 × 105, 1 × 106, and 1.5 × 106 iterations, respectively. The
GIPG step scaling term referred to as λ was set to 0.9. GIPG
algorithm can be obtained from the website† as an Igor Pro
6.03 procedure file.
Dynamic light scattering
Fluctuations of scattered light intensity were measured
using a homodyne technique. At a particular incubation time
x, the intensity correlation function g2(t,x) was measured by a
modified Nicomp Model 380 Particle Size Analyzer (Particle
Sizing Systems). Scattered light from the incident laser
(λ = 532 nm) was collected orthogonally (θ = 90°). The system
employs a linearly scaled 64-channel digital autocorrelator.
For experiments completed in this study, the native
autocorrelator was bypassed by an ALV-6010 Multi-Tau
autocorrelator (ALV GmbH, Langen, Germany) for the
maximum possible statistical accuracy across several
orders of magnitude in decay time.85
Round borosilicate glass cuvettes (Kimble Glass) were
used for all DLS measurements. In order to minimize dust
contamination, each cuvette was rinsed with Millipore
water. Cuvettes were placed in a microcentrifuge, inverted
(open side face down), then spun dry and stored face down.
After the sample had been quickly and carefully added to
the cuvette, it was covered with transparent tape to keep it
dust-free, then wrapped in Parafilm for an additional seal.
For the 28-day DLS study, 250 μL of incubated sample
was placed in a clean dry cuvette. Twenty correlation
functions were measured sequentially for 30 s apiece for
each incubated sample. The cuvette chamber was held at a
constant temperature of 37 °C. For the continuous† http://talaga.rutgers.edu
acquisition incubation, the same sample was analyzed
every 15 min for 5 min at 37 °C for 4.7 days.
The distribution of decay rates f(Γ,x) for a particular
incubation time point x is related to the field correlation
function g1(t,x) by:
Z l
e Gt f ðG,xÞdG
ð1Þ
g1 ðt,xÞ ¼
0
where f(Γ,x) can be solved for by the inverse Laplace
transform. In most cases, the intensity and field correlation
functions
ffiffiffiffi be related via the Siegert relation, such that
pffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffican
g2 ðt,xÞ 1~g1 ðt,xÞ.85
GIPG was originally demonstrated by globally fitting
TCSPC transients, but it can be also employed to globally
fit many types of spectroscopic data that require an
inverse Laplace transform, such as in Eq. (1), as long as
there is piecewise continuity in the experimental domain
x. One difference is that the intensity correlation functions
do not require instrument response convolution of the
basis set. Another difference is that the standard deviations for the data were calculated in real time by the ALV6010 correlator using a noise model.
DLS data were globally fitted onto a 50-point grid with
logarithmically spaced decay times Γ− 1 ranging from
0.001 to 65 ms. A baseline term was included. The total
number of correlation functions used in the short-term
DLS fit was reduced from 340 to 34 by averaging every 10
correlation functions into a single trace and by propagating the error accordingly. The probability to reject the
GIPG solution for both data sets was b10− 4.
In DLS, a particle's decay time is related to the
translational diffusion constant through the scattering
vector q, such that D = Γ/q2, where q = 4π/λ sin(θ/2). The
diffusion constant can then be converted into Stokes
hydrodynamic radius (RH) using the Stokes–Einstein
relation RH = (kBT)/(6πη0D), assuming a spherical shape.
For these experiments, T is the temperature, η0 is the
refractive index of the buffer, and kB is the Boltzmann
constant. The characteristic density of the partially
unfolded monomer determined from assignment of a
urea titration DLS experiment at 5.0 M was used to scale
the oligomer sizes.
Atomic force microscopy
To obtain better adhesion of protein aggregates to a
mica surface, chemical surface modification was implemented. Twenty microliters of 0.1 (vol/vol) APTES was
applied evenly on a freshly cleaved 9.9-mm-diameter mica
disk. After 10 min, unreacted APTES was rinsed away
with 15 mL of 0.2 μM filtered deionized water. The surface
was blown dry with high-purity compressed nitrogen gas.
Incubated sample was applied evenly on a freshly
prepared surface for 10 min. Unbound species were rinsed
away with Millipore water. The sample was again dried
with nitrogen gas before being imaged with a MultiMode
Scanning Probe Microscope (Digital Instruments) with a
TESP tip in tapping mode.
Acknowledgements
This work was supported by grant R01GM071684
from the National Institutes of Health. J.T.G. was
supported by a Graduate Assistantship in Areas of
1346
National Need grant to the Department of Chemistry and Chemical Biology. We thank Ben Strangfeld for assisting with the DLS experiments, Troy
Messina for IMPACT minimizations, and Richard
Ebright for the use of the atomic force microscope.
References
1. Sipe, J. D. & Cohen, A. S. (2000). Review: history of the
amyloid fibril. J. Struct. Biol. 130, 88–98.
2. Walsh, D. M., Hartley, D. M. & Selkoe, D. J. (2003). The
many faces of aβ: structures and activity. Curr. Med.
Chem. Immunol. Endocr. Metab. Agents, 3, 277–291.
3. Wetzel, R. (2002). Ideas of order for amyloid fibril
structure. Structure, 10, 1031–1036.
4. Solomon, B. (2002). Towards Alzheimer's disease
vaccination. Mini-Rev. Med. Chem. 2, 85–92.
5. Kirkitadze, M. D., Bitan, G. & Teplow, D. B. (2002).
Paradigm shifts in Alzheimer's disease and other
neurodegenerative disorders: the emerging role of
oligomeric assemblies. J. Neurosci. Res. 69, 567–577.
6. Hardy, J. & Selkoe, D. J. (2002). The amyloid
hypothesis of Alzheimer's disease: progress and
problems on the road to therapeutics. Science, 297,
353–356.
7. Chiti, F. & Dobson, C. (2006). Protein misfolding,
functional amyloid, and human disease. Annu. Rev.
Biochem. 75, 333–366.
8. Teplow, D. B. (1998). Structural and kinetic features of
amyloid β-protein fibrillogenesis. Amyloid, 5, 121–142.
9. Rochet, J.-C., Lansbury, J. & Peter, T. (2000). Amyloid
fibrillogenesis: themes and variations. Curr. Opin.
Struct. Biol. 10, 60–68.
10. Murphy, R. M. & Pallitto, M. M. (2000). Probing the
kinetics of β-amyloid self-association. J. Struct. Biol.
130, 109–122.
11. Zerovnik, E. (2002). Amyloid-fibril formation. Proposed mechanisms and relevance to conformational
disease. Eur. J. Biochem. 269, 3362–3371.
12. Nielsen, L., Khurana, R., Coats, A., Frokjaer, S.,
Brange, J. & Vyas, S. (2001). Effect of environmental
factors on the kinetics of insulin fibril formation:
elucidation of the molecular mechanism. Biochemistry,
40, 6036–6046.
13. Hamada, D. & Dobson, C. M. (2002). A kinetic study
of β-lactoglobulin amyloid fibril formation promoted
by urea. Protein Sci. 11, 2417–2426.
14. Lee, C.-C., Nayak, A., Sethuraman, A., Belfort, G. &
McRae, G. J. (2007). A three-stage kinetic model of
amyloid fibrillation. Biophys. J. 92, 3448–3458.
15. Lomakin, A., Teplow, D. B., Kirschner, D. A. &
Benedek, G. B. (1997). Kinetic theory of fibrillogenesis
of amyloid β-protein. Proc. Natl Acad. Sci. USA, 94,
7942–7947.
16. Pappu, R. V., Wang, X., Vitalis, A. & Crick, S. L. (2008).
A polymer physics perspective on driving forces and
mechanisms for protein aggregation. Arch. Biochem.
Biophys. 469, 132–141.
17. Pallitto, M. M. & Murphy, R. M. (2001). A mathematical model of the kinetics of β-amyloid fibril
growth from the denatured state. Biophys. J. 81,
1805–1822.
18. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M.,
Milton, S. C., Cotman, C. W. & Glabe, C. G. (2003).
Common structure of soluble amyloid oligomers
implies common mechanism of pathogenesis. Science,
300, 486–489.
β-Lactoglobulin Assembly into Amyloid
19. Kane, M. D., Lipinski, W. J., Callahan, M. J., Bian, F.,
Durham, R. A., Schwarz, R. D. et al. (2000). Evidence
for seeding of β-amyloid by intracerebral infusion of
Alzheimer brain extracts in β-amyloid precursor
protein-transgenic mice. J. Neurosci. 20, 3606–3611.
20. Harper, J. D. & Lansbury, P. T., Jr (1997). Models of
amyloid seeding in Alzheimer's disease and scrapie:
mechanistic truths and physiological consequences of
the time-dependent solubility of amyloid proteins.
Annu. Rev. Biochem. 66, 385–407.
21. Stöhr, J., Weinmann, N., Wille, H., Kaimann, T., NagelSteger, L., Birkmann, E. et al. (2008). Mechanisms of
prion protein assembly into amyloid. Proc. Natl Acad.
Sci. USA, 105, 2409–2414.
22. Andrews, J. M. & Roberts, C. J. (2007). A Lumry–Eyring
nucleated polymerization model of protein aggregation kinetics: 1. Aggregation with pre-equilibrated
unfolding. J. Phys. Chem. B, 111, 7897–7913.
23. Goldsbury, C., Kistler, J., Aebi, U., Arvinte, T. &
Cooper, G. J. S. (1999). Watching amyloid fibrils grow
by time-lapse atomic force microscopy. J. Mol. Biol.
285, 33–39.
24. Stolz, M., Stoffler, D., Aebi, U. & Goldsbury, C.
(2000). Monitoring biomolecular interactions by timelapse atomic force microscopy. J. Struct. Biol. 131,
171–180.
25. Gosal, W. S., Clark, A. H., Pudney, P. D. A. & RossMurphy, S. B. (2002). Novel amyloid fibrillar networks
derived from a globular protein: β-lactoglobulin.
Langmuir, 18, 7174–7181.
26. Parbhu, A., Lin, H., Thimm, J. & Lal, R. (2002).
Imaging real-time aggregation of amyloid β protein
(1–42) by atomic force microscopy. Peptides, 23,
1265–1270.
27. Kusumoto, Y., Lomakin, A., Teplow, D. B. & Benedek,
G. B. (1998). Temperature dependence of amyloid βprotein fibrillization. Proc. Natl Acad. Sci. USA, 95,
12277–12282.
28. Bergasa-Caceres, F. & Rabitz, H. A. (2003). Two-state
folding kinetics of small proteins in the sequential
collapse model: dependence of the folding rate on
contact order and temperature. J. Phys. Chem. B, 107,
12874–12877.
29. Prusiner, S. B. (1982). Novel proteinaceous infectious
particles cause scrapie. Science, 216, 136–144.
30. Griffith, J. S. (1967). Self-replication and scrapie.
Nature, 215, 1043–1044.
31. Schenk, D. (2002). Opinion: amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning.
Nat. Rev. Neurosci. 3, 824–828.
32. Satheeshkumar, K. S. & Jayakumar, R. (2003). Conformational polymorphism of the amyloidogenic
peptide homologous to residues 113–127 of the prion
protein. Biophys. J. 85, 473–483.
33. Bouchard, M., Zurdo, J., Nettleton, E. J., Dobson, C. M.
& Robinson, C. V. (2000). Formation of insulin amyloid
fibrils followed by FTIR simultaneously with CD and
electron microscopy. Protein Sci. 9, 1960–1967.
34. Lansbury, J., Peter, T., Costa, P. R., Griffiths, J. M.,
Simon, E. J., Auger, M. et al. (1995). Structural model
for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal
peptide. Nat. Struct. Biol. 2, 990–998.
35. Chiti, F., Webster, P., Taddei, N., Clark, A., Stefani, M.,
Ramponi, G. & Dobson, C. M. (1999). Designing
conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl Acad. Sci. USA, 96,
3590–3594.
36. Abe, H. & Nakanishi, H. (2003). Novel observation of
β-Lactoglobulin Assembly into Amyloid
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
a circular dichroism band originating from amyloid
fibril. Anal. Sci. 19, 171–173.
Carrotta, R., Bauer, R., Waninge, R. & Rischel, C.
(2001). Conformational characterization of oligomeric
intermediates and aggregates in β-lactoglobulin heat
aggregation. Protein Sci. 10, 1312–1318.
Baskakov, I. V., Legname, G., Baldwin, M. A.,
Prusiner, S. B. & Cohen, F. E. (2002). Pathway
complexity of prion protein assembly into amyloid.
J. Biol. Chem. 277, 21140–21148.
Quintas, A., Saraiva, M. J. & Brito, R. M. (1999). The
tetrameric protein transthyretin dissociates to a nonnative monomer in solution. A novel model for
amyloidogenesis. J. Biol. Chem. 274, 32943–32949.
Safar, J., Roller, P. P., Gajdusek, D. C. & Gibbs, C. J., Jr
(1994). Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate. Biochemistry, 33, 8375–8383.
Srisailam, S., Kumar, T. K., Rajalingam, D., Kathir,
K. M., Sheu, H.-S., Jan, F.-J. et al. (2003). Amyloid-like
fibril formation in an all β-barrel protein. Partially
structured intermediate state(s) is a precursor for
fibril formation. J. Biol. Chem. 278, 17701–17709.
Gorman, P. M. & Chakrabartty, A. (2001). Alzheimer βamyloid peptides: structures of amyloid fibrils and alternate aggregation products. Biopolymers, 60, 381–394.
Huang, T. H. J., Yang, D.-S., Fraser, P. E. &
Chakrabartty, A. (2000). Alternate aggregation pathways of the Alzheimer β-amyloid peptide. An in vitro
model of preamyloid. J. Biol. Chem. 275, 36436–36440.
Banks, J. L., Beard, H. S., Cao, Y., Cho, A. E., Damm, W.,
Farid, R. et al. (2005). Integrated modeling program,
applied chemical theory (IMPACT). J. Comput. Chem.
26, 1752–1780.
Uhrinova, S., Smith, M. H., Jameson, G. B., Uhrin, D.,
Sawyer, L. & Barlow, P. N. (2000). Structural changes
accompanying pH-induced dissociation of the βlactoglobulin dimer. Biochemistry, 39, 3565–3574.
Sawyer, L. & Kontopidis, G. (2000). The core lipocalin,
bovine β-lactoglobulin. Biochim. Biophys. Acta, 1482,
136–148.
Sagis, L. M. C., Veerman, C. & Van der Linden, E.
(2004). Mesoscopic properties of semiflexible amyloid
fibrils. Langmuir, 20, 924–927.
Buck, M. (1998). Trifluoroethanol and colleagues:
cosolvents come of age. Recent studies with peptides
and proteins. Q. Rev. Biophys. 31, 297–355.
Chikenji, G. & Kikuchi, M. (2000). What is the role of
non-native intermediates of β-lactoglobulin in protein
folding? Proc. Natl Acad. Sci. USA, 97, 14273–14277.
Forge, V., Hoshino, M., Kuwata, K., Arai, M.,
Kuwajima, K., Batt, C. A. & Goto, Y. (2000). Is folding
of β-lactoglobulin non-hierarchic? Intermediate with
native-like β-sheet and non-native α-helix. J. Mol. Biol.
296, 1039–1051.
Hamada, D. & Goto, Y. (1997). The equilibrium
intermediate of β-lactoglobulin with non-native αhelical structure. J. Mol. Biol. 269, 479–487.
Hamada, D., Segawa, S.-I. & Goto, Y. (1996). Nonnative α-helical intermediate in the refolding of βlactoglobulin, a predominantly β-sheet protein. Nat.
Struct. Biol. 3, 868–873.
Kuwata, K., Hoshino, M., Era, S., Batt, C. A. & Goto, Y.
(1998). α → β transition of β-lactoglobulin as evidenced
by heteronuclear NMR. J. Mol. Biol. 283, 731–739.
Bergasa-Caceres, F. & Rabitz, H. A. (2003). Sequential
collapse folding pathway of β-lactoglobulin: parallel
pathways and non-native secondary structure. J. Phys.
Chem. B, 107, 3606–3612.
1347
55. Kuwajima, K., Yamaya, H. & Sugai, S. (1996). The
burst-phase intermediate in the refolding of β-lactoglobulin studied by stopped-flow circular dichroism and
absorption spectroscopy. J. Mol. Biol. 264, 806–822.
56. Kuwata, K., Shastry, R., Cheng, H., Hoshino, M., Batt,
C. A., Goto, Y. & Roder, H. (2001). Structural and
kinetic characterization of early folding events in βlactoglobulin. Nat. Struct. Biol. 8, 151–155.
57. Kella, N. K. & Kinsella, J. E. (1988). Structural stability
of β-lactoglobulin in the presence of kosmotropic
salts. A kinetic and thermodynamic study. Int. J. Pept.
Protein Res. 32, 396–405.
58. Creamer, L. K. (1995). Effect of sodium dodecyl sulfate
and palmitic acid on the equilibrium unfolding of
bovine β-lactoglobulin? Biochemistry, 34, 7170–7176.
59. D'Alfonso, L., Collini, M. & Baldini, G. (2003).
Trehalose influence on β-lactoglobulin stability and
hydration by time resolved fluorescence. Eur. J.
Biochem. 270, 2497–2504.
60. Kirk, W., Kurian, E. & Wessels, W. (2007). Photophysics of ANS v. decay modes of ANS in proteins:
the IFABP–ANS complex. Biophys. Chem. 125, 50–58.
61. Gasymov, O. K., Abduragimov, A. R. & Glasgow, B. J.
(2007). Characterization of fluorescence of ANS–tear
lipocalin complex: evidence for multiple-binding
modes. Photochem. Photobiol. 83, 1405–1414.
62. Khurana, R., Gillespie, J. R., Talapatra, A., Minert, L. J.,
Ionescu-Zanetti, C., Millett, I. & Fink, A. L. (2001).
Partially folded intermediates as critical precursors of
light chain amyloid fibrils and amorphous aggregates.
Biochemistry, 40, 3525–3535.
63. Lindgren, M., Sorgjerd, K. & Hammarstromy, P. (2005).
Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using
fluorescence spectroscopy. Biophys. J. 88, 4200–4212.
64. Giurleo, J. T. & Talaga, D. S. (2008). Global fitting
without a global model: regularization based on the
continuity of the evolution of parameter distributions.
J. Chem. Phys. 128, 114114; (1–18).
65. Lomakin, A., Benedek, G. B. & Teplow, D. B. (1999).
Monitoring protein assembly using quasielastic light
scattering spectroscopy. Methods Enzymol. 309,
429–459.
66. Modler, A. J., Gast, K., Lutsch, G. & Damaschun, G.
(2003). Assembly of amyloid protofibrils via critical
oligomers—a novel pathway of amyloid formation. J.
Mol. Biol. 325, 135–148.
67. Waldrop, F. S., Puchtler, H. & Meloan, S. N. (1984).
Fluorescent thiazole stains for amyloid without
differentiation. J. Histotechnol. 7, 123–126.
68. Elhaddaoui, A., Delacourte, A. & Turrell, S. (1993).
Spectroscopic study of Congo red and thioflavin
binding to amyloid-like proteins. J. Mol. Struct. 294,
115–118.
69. LeVine, H. (1995). Thioflavine T interaction with
amyloid β-sheet structures. Amyloid, 2, 1–6.
70. Ban, T., Hamada, D., Hasegawa, K., Naiki, H. & Goto,
Y. (2003). Direct observation of amyloid fibril growth
monitored by thioflavin T fluorescence. J. Biol. Chem.
278, 16462–16465.
71. Schirra, R. (1985). Dye aggregation in freezing aqueous
solutions. Chem. Phys. Lett. 119, 463–466.
72. Retna Raj, R. R. C. (1997). γ-Cyclodextrin induced
intermolecular excimer formation of thioflavin T.
Chem. Phys. Lett. 273, 285–290.
73. Groenning, M., Olsen, L., van de Weert, M., Flink, J. M.,
Frokjaer, S. & Jørgensen, F. S. (2007). Study on the
binding of thioflavin T to β-sheet-rich and non-β-sheet
cavities. J. Struct. Biol. 158, 358–369.
1348
74. Weiss, W. F., Hodgdon, T. K., Kaler, E. W., Lenhoff,
A. M. & Roberts, C. J. (2007). Nonnative protein
polymers: structure, morphology, and relation to
nucleation and growth. Biophys. J. 93, 4392–4403.
75. Gaczynska, M. & Osmulski, P. A. AFM of biological
complexes: what can we learn? Curr. Opin. Colloid
Interface Sci. In press. doi:10.1016/j.cocis.2008.01.004.
76. D'Alfonso, L., Collini, M. & Baldini, G. (2002). Does βlactoglobulin denaturation occur via an intermediate
state? Biochemistry, 41, 326–333.
77. Strickler, S. J. & Berg, R. A. (1962). Relationship
between absorption intensity and fluorescence lifetime of molecules. J. Chem. Phys. 37, 814–822.
78. Miller, D. W. & Dill, K. A. (1997). Ligand binding to
proteins: the binding landscape model. Protein Sci. 6,
2166–2179.
79. Dobson, C. M. (1999). Protein misfolding, evolution
and disease. Trends Biochem. Sci. 24, 329–332.
80. Crick, S. L., Jayaraman, M., Frieden, C., Wetzel, R. &
Pappu, R. V. (2006). Fluorescence correlation spectro-
β-Lactoglobulin Assembly into Amyloid
81.
82.
83.
84.
85.
scopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions.
Proc. Natl Acad. Sci. USA, 103, 16764–16769.
Vitalis, A., Wang, X. & Pappu, R. V. (2007). Quantitative characterization of intrinsic disorder in polyglutamine: insights from analysis based on polymer
theories. Biophys. J. 93, 1923–1937.
Messina, T. C., Kim, H., Giurleo, J. T. & Talaga, D. S.
(2006). Hidden Markov model analysis of multichromophore photobleaching. J. Phys. Chem. B, 110, 16366–16376.
Lawson, C. L. & Hanson, R. J. (1974). Solving Least
Squares Problems. Prentice-Hall, Inc., Englewood Cliffs,
NJ.
Provencher, S. W. (1982). A constrained regularization
method for inverting data represented by linear
algebraic or integral equations. Comput. Phys. Commun.
27, 213–227.
Brown, W. (ed). (1993). Dynamic Light Scattering: The
Method and Some Applications Oxford Science
Publications, New York City, NY.